# Rafarm S.A. – FDA Inspection, May 31, 2018

Source: https://www.keypedia.com/records/fda_inspections/rafarm-sa/6429f57b-1cfa-49d1-9f63-9c745663982a
Source feed: FDA_Inspections

> FDA inspection 1111463 of Rafarm S.A., May 31, 2018. Classification: Voluntary Action Indicated (VAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1111463
- Company Name: Rafarm S.A.
- Inspection Date: 2018-05-31
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1300434 - 2024-06-21
- [FDA Inspection 1225663 - 2023-05-19](https://www.keypedia.com/records/fda_inspections/rafarm-sa/b8f780cb-150f-479c-972b-49798ad3c1d3)
- FDA Inspection 1155967 - 2021-06-04
- FDA Inspection 1123693 - 2020-03-11
- FDA Inspection 1101881 - 2019-07-30

## Related Officers

- Issuing Officer

Company: https://www.keypedia.com/companies/rafarm-sa/147e9812-6247-4b31-82b4-c444b23955ce

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
